|
FY2026
12 months to Feb 28, 2026
|
FY2025
12 months to Mar 1, 2025
|
FY2024
12 months to Mar 2, 2024
|
FY2023
12 months to Feb 25, 2023
|
FY2022
12 months to Feb 26, 2022
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net earnings | |||||
| Adjustments to reconcile net earnings to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Share-based compensation | |||||
| Deferred income taxes | |||||
| Asset impairment on property, plant and equipment | |||||
| Loss (gain) on disposal of property, plant and equipment | |||||
| Impairment of long-lived assets | |||||
| Proceeds from New Markets Tax Credit transaction, net of deferred costs | |||||
| Settlement of New Markets Tax Credit transaction | |||||
| Non-cash lease expense | |||||
| Other, net | |||||
| Changes in operating assets and liabilities: | |||||
| Receivables | |||||
| Inventories | |||||
| Contract assets | |||||
| Accounts payable | |||||
| Accrued compensation and benefits | |||||
| Contract liabilities | |||||
| Operating lease liability | |||||
| Accrued income taxes | |||||
| Other current assets and liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing Activities | |||||
| Capital expenditures | |||||
| Proceeds from sales of property, plant and equipment | |||||
| Purchases of marketable securities | |||||
| Sales/maturities of marketable securities | |||||
| Acquisition of business, net of cash acquired | |||||
| Net cash used by investing activities | |||||
| Financing Activities | |||||
| Proceeds from revolving credit facilities | |||||
| Proceeds from exercise of stock options | |||||
| Repayment on revolving credit facilities | |||||
| Proceeds from term loans | |||||
| Repayment of term loans | |||||
| Payments of debt issuance costs | |||||
| Repurchase of common stock | |||||
| Dividends paid | |||||
| Other, net | |||||
| Net cash (used by) provided by financing activities | |||||
| Effect of exchange rates on cash | |||||
| (Decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Non-cash Activity | |||||
| Capital expenditures in accounts payable | |||||
Loading...